238 related articles for article (PubMed ID: 33375604)
1. Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1.
Désaulniers K; Ortiz L; Dufour C; Claudel A; Plourde MB; Merindol N; Berthoux L
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375604
[TBL] [Abstract][Full Text] [Related]
2. Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1.
Dufour C; Claudel A; Joubarne N; Merindol N; Maisonnet T; Masroori N; Plourde MB; Berthoux L
PLoS One; 2018; 13(1):e0191709. PubMed ID: 29373607
[TBL] [Abstract][Full Text] [Related]
3. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
[TBL] [Abstract][Full Text] [Related]
4. A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.
OhAinle M; Helms L; Vermeire J; Roesch F; Humes D; Basom R; Delrow JJ; Overbaugh J; Emerman M
Elife; 2018 Dec; 7():. PubMed ID: 30520725
[TBL] [Abstract][Full Text] [Related]
5. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
[TBL] [Abstract][Full Text] [Related]
6. Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning.
Cloherty APM; Rader AG; Compeer B; Ribeiro CMS
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669846
[TBL] [Abstract][Full Text] [Related]
7. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
[TBL] [Abstract][Full Text] [Related]
9. Disrupting HIV-1 capsid formation causes cGAS sensing of viral DNA.
Sumner RP; Harrison L; Touizer E; Peacock TP; Spencer M; Zuliani-Alvarez L; Towers GJ
EMBO J; 2020 Oct; 39(20):e103958. PubMed ID: 32852081
[TBL] [Abstract][Full Text] [Related]
10. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene.
Jung U; Urak K; Veillette M; Nepveu-Traversy MÉ; Pham QT; Hamel S; Rossi JJ; Berthoux L
Hum Gene Ther; 2015 Oct; 26(10):664-79. PubMed ID: 26076730
[TBL] [Abstract][Full Text] [Related]
12. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
[TBL] [Abstract][Full Text] [Related]
13. Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study.
Amanya SB; Nyiro B; Waswa F; Obura B; Nakaziba R; Nabulime E; Katabazi AF; Nabatanzi R; Bayiyana A; Mboowa G; Kayongo A; Wayengera M; Sande OJ
Retrovirology; 2020 Jul; 17(1):19. PubMed ID: 32631377
[TBL] [Abstract][Full Text] [Related]
14. A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen.
Pham QT; Veillette M; Brandariz-Nuñez A; Pawlica P; Thibert-Lefebvre C; Chandonnet N; Diaz-Griffero F; Berthoux L
Virus Res; 2013 May; 173(2):306-314. PubMed ID: 23357295
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
16. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor.
Passos V; Zillinger T; Casartelli N; Wachs AS; Xu S; Malassa A; Steppich K; Schilling H; Franz S; Todt D; Steinmann E; Sutter K; Dittmer U; Bohne J; Schwartz O; Barchet W; Goffinet C
J Virol; 2019 Dec; 93(24):. PubMed ID: 31597782
[TBL] [Abstract][Full Text] [Related]
18. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
[TBL] [Abstract][Full Text] [Related]
19. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
